Evolent Health, Inc. Cash and Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect
Evolent Health, Inc. (EVH) reported Cash and Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect of $152.58 million for the 9-month period ending 2017-09-30, per its 10-Q filed 2017-11-09.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect · last filed 2017-11-09
- 2017-09-30: Cash and Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 9 month $152.58M.
- 2016-09-30: Cash and Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 9 month -$35.95M.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 9 month |
|---|---|
| 2017-09-30 | $152.58M 10-Q · filed 2017-11-09 |
| 2016-09-30 | -$35.95M 10-Q · filed 2017-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FRANKLIN COVEY CO (FC) | United States | $0.195B | 123.76 |
| GARTNER INC (IT) | United States | $11.326B | 11.20 |